National Research Co. (NASDAQ:NRC – Get Free Report) shares saw unusually-strong trading volume on Thursday . Approximately 178,489 shares changed hands during trading, an increase of 124% from the previous session’s volume of 79,638 shares.The stock last traded at $22.94 and had previously closed at $23.00.
National Research Price Performance
The company has a 50 day moving average of $29.28 and a 200 day moving average of $35.60. The company has a quick ratio of 0.41, a current ratio of 0.41 and a debt-to-equity ratio of 0.75. The stock has a market capitalization of $548.05 million, a price-to-earnings ratio of 18.51 and a beta of 0.56.
National Research (NASDAQ:NRC – Get Free Report) last released its quarterly earnings data on Tuesday, May 7th. The company reported $0.27 EPS for the quarter. National Research had a return on equity of 54.83% and a net margin of 20.60%. The business had revenue of $35.31 million during the quarter.
National Research Announces Dividend
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of NRC. Vanguard Group Inc. grew its stake in National Research by 1.1% in the third quarter. Vanguard Group Inc. now owns 980,693 shares of the company’s stock worth $43,513,000 after purchasing an additional 10,454 shares in the last quarter. Conestoga Capital Advisors LLC increased its stake in National Research by 0.5% during the first quarter. Conestoga Capital Advisors LLC now owns 784,656 shares of the company’s stock valued at $31,080,000 after purchasing an additional 3,850 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of National Research by 1.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 636,402 shares of the company’s stock worth $25,176,000 after buying an additional 7,531 shares during the last quarter. iA Global Asset Management Inc. acquired a new stake in National Research during the third quarter worth about $11,124,000. Finally, Comerica Bank acquired a new position in National Research in the third quarter valued at approximately $6,939,000. Institutional investors and hedge funds own 47.26% of the company’s stock.
National Research Company Profile
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
See Also
- Five stocks we like better than National Research
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Insider Trades May Not Tell You What You Think
- MarketBeat Week in Review – 6/24 – 6/28
- 3 Ways To Invest In Coffee, Other Than Drinking It
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.